The antioxidant effect of scutellarin on NAFLD is dependent on PI3K/AKT activation with subsequent Nrf2 nuclear translocation, which increases the expression of HO-1 (58). The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.